Focusing on pediatric psychopharmacology, this title covers the emerging question of treating children who do not yet meet diagnostic criteria for psychosis, such as schizophrenia or bipolar disorder, but who are deemed to be at high risk. It addresses concerns about cardiovascular side effects of the stimulant medications available.